Attention Deficit Hyperactivity Disorder clinical trials
- Phase
- Phase 3
- Phase
- Phase 2
Access comprehensive clinical trial information for Attention Deficit Hyperactivity Disorder through Pure Global AI's free database. This collection includes 394 clinical trials across multiple phases including N/A, Phase 4, Phase 3. Currently, 41 trials are actively recruiting participants.
Research for Attention Deficit Hyperactivity Disorder is being conducted in United States of America, Taiwan, China and 7+ other countries. Leading sponsors include Eli Lilly and Company and Children's Hospital Medical Center, Cincinnati. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 394 clinical trials studying Attention Deficit Hyperactivity Disorder, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Eli Lilly and Company, Children's Hospital Medical Center, Cincinnati, National Taiwan University Hospital, among others.